Showing results (221-230 of 470) with videos related to

Sort By:
Pageof 47
Cancer Immunology, Immunotherapy : CII|July 22, 1998
The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29S Bungard, D Flieger, S Schweitzer, et al.
Deutsche Medizinische Wochenschrift (1946)|September 27, 1996
[Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C]J Heller, J Musiolik, A Homrighausen, et al.
European Journal of Gastroenterology & Hepatology|January 1, 1996
Prevalence of and risk factors for Helicobacter pylori infection in the western part of GermanyT Breuer, T Sudhop, J Hoch, et al.
Hepato-Gastroenterology|June 17, 1999
Prediction of the lower esophageal sphincter pressure after oral molsidomine by sydnonimine plasma concentrationsB Stoschus, I Fernandez, J Heller, et al.
Annals of Hematology|March 10, 2001
Littoral cell angioma as a rare cause of splenomegalyC Ziske, M Meybehm, T Sauerbruch, et al.
Der Internist|November 10, 2007
[Medical therapy of complications in liver cirrhosis]F Grünhage, J Heller, B Appenrodt, et al.
Zeitschrift Fur Gastroenterologie|October 22, 2008
Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patientA Höblinger, K Tiemann, G Nickenig, et al.
Deutsche Medizinische Wochenschrift (1946)|January 8, 1988
[Prognostic parameters in liver cirrhosis, varicose bleeding and sclerosing therapy. Prospective comparison of a prognostic system with the Child classification obtained by discriminant analysis]T Sauerbruch, H Ansari, R Wotzka, et al.
Biochimica Et Biophysica Acta|March 29, 1996
Formation of cholic acid and chenodeoxycholic acid from 7 alpha-hydroxycholesterol and 27-hydroxycholesterol by primary cultures of human hepatocytesG Sauter, S Fischer, S Pahernik, et al.
Zeitschrift Fur Gastroenterologie|February 20, 1999
[Successful conservative therapy of hepatorenal syndrome with vasopressin-1-receptor antagonist ornipressin]V Gülberg, P Luppa, J Pauletzki, et al.
Pageof 47